ASTH Earnings & Financial Statements
Astrana Health, Inc.
$37.55
+$1.68(+4.68%)
62
Overall
65
Value
80
Tech
42
Quality
Market Cap
$1.78B
Volume
314.94K
52W Range
$18.08 - $51.60
Target Price
$50.22
ASTH earnings and financial statements: Astrana Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ASTH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.91M |
| Cost of revenue | $2.84B | $1.76B | $1.17B | $944.68M | $596.14M |
| Operating income | $78.53M | $89.35M | $84.61M | $104.27M | $98.18M |
| EBITDA | $139.33M | $143.67M | $124.75M | $113.02M | $104.98M |
| Net income | $22.49M | $43.15M | $60.72M | $45.17M | $68.92M |
| EPS (diluted) | $0.46 | $0.90 | $1.29 | $1.08 | $1.63 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.22B | $1.35B | $933.36M | $966.21M | $852.36M |
| Total liabilities | $1.66B | $840.73M | $522.59M | $407.67M | $336.36M |
| Shareholders’ equity | $779.29M | $712.72M | $614.22M | $542.56M | $454.55M |
| Cash and equivalents | $429.47M | $288.45M | $293.81M | $288.03M | $233.10M |
| Long-term debt | $1.02B | $455.95M | $296.26M | $224.58M | $197.09M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $114.60M | $52.20M | $68.23M | $82.13M | $70.33M |
| Capital expenditure | -$10.11M | -$8.03M | -$28.53M | -$22.94M | -$19.22M |
| Free cash flow | $104.49M | $44.17M | $39.70M | $82.13M | $51.11M |
| Dividends paid | $7.88M | $4.04M | $62.15M | - | $32.56M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASTH | $37.55 | +4.7% | 314.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |